Agm Labza Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores

Secondary Activities: Electrical Contractors and Other Wiring Installation Contractors | Other Building Finishing Contractors | Site Preparation Contractors | Other Furniture Related Product Manufacturing | Medical Equipment and Supplies Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Data Processing, Hosting, and Related Services | Computer Systems Design and Related Services | Electronic and Precision Equipment Repair and Maintenance

Full name: Agm Labza Sp. z o.o.

Profile Updated: May 20, 2025

Agm Labza Sp. z o.o. is based in Poland, with the head office in Krakow. The enterprise currently operates in the Pharmacies and Drug Stores sector. Agm Labza Sp. z o.o. was incorporated on January 03, 2024. The latest financial highlights indicate a net sales revenue drop of 21.88% in 2024. During that time, Agm Labza Sp. z o.o.’s total assets decreased by 10.96%. In 2024, Agm Labza Sp. z o.o.’s net profit margin decreased by 4.16%.

Headquarters
Ul. Balicka 116B/G
Krakow; Malopolskie; Postal Code: 30-149

Contact Details: Purchase the Agm Labza Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Agm Labza Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Agm Labza Sp. z o.o. report to view the information.

Incorporation Date:

January 03, 2024

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Agm Labza Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

-21.88%▼

Total operating revenue

-22.01%▼

Operating profit (EBIT)

-51.66%▼

EBITDA

-50.61%▼

Net Profit (Loss) for the Period

-60.18%▼

Total Assets

-10.96%▼

Total Equity

9.86%▲

Operating Profit Margin (ROS)

-2.94%▼

Net Profit Margin

-4.16%▼

Return on Equity (ROE)

-83.2%▼

Quick Ratio

-0.08%▼

Cash Ratio

0.13%▲

Similar companies